178 related articles for article (PubMed ID: 35246559)
1. A reference set of clinically relevant adverse drug-drug interactions.
Kontsioti E; Maskell S; Dutta B; Pirmohamed M
Sci Data; 2022 Mar; 9(1):72. PubMed ID: 35246559
[TBL] [Abstract][Full Text] [Related]
2. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
3. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
4. Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug-drug interactions.
Kontsioti E; Maskell S; Pirmohamed M
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):832-844. PubMed ID: 36916014
[TBL] [Abstract][Full Text] [Related]
5. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
6. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
7. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
[TBL] [Abstract][Full Text] [Related]
8. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
Yang CC; Yang H
Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
[TBL] [Abstract][Full Text] [Related]
9. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.
Wang X; Li L; Wang L; Feng W; Zhang P
Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829
[TBL] [Abstract][Full Text] [Related]
10. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports.
Cai R; Liu M; Hu Y; Melton BL; Matheny ME; Xu H; Duan L; Waitman LR
Artif Intell Med; 2017 Feb; 76():7-15. PubMed ID: 28363289
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.
Noguchi Y; Tachi T; Teramachi H
Pharm Res; 2020 Apr; 37(5):86. PubMed ID: 32356247
[TBL] [Abstract][Full Text] [Related]
12. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
[TBL] [Abstract][Full Text] [Related]
13. Mining clinical text for signals of adverse drug-drug interactions.
Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH
J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091
[TBL] [Abstract][Full Text] [Related]
14. Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
Bailey S; Singh A; Azadian R; Huber P; Blum M
Drug Saf; 2010 Feb; 33(2):139-46. PubMed ID: 20082540
[TBL] [Abstract][Full Text] [Related]
15. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.
Vilar S; Friedman C; Hripcsak G
Brief Bioinform; 2018 Sep; 19(5):863-877. PubMed ID: 28334070
[TBL] [Abstract][Full Text] [Related]
16. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
[TBL] [Abstract][Full Text] [Related]
17. Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.
Osokogu OU; Fregonese F; Ferrajolo C; Verhamme K; de Bie S; 't Jong G; Catapano M; Weibel D; Kaguelidou F; Bramer WM; Hsia Y; Wong IC; Gazarian M; Bonhoeffer J; Sturkenboom M
Drug Saf; 2015 Feb; 38(2):207-17. PubMed ID: 25663078
[TBL] [Abstract][Full Text] [Related]
18. A Text Mining Protocol for Extracting Drug-Drug Interaction and Adverse Drug Reactions Specific to Patient Population, Pharmacokinetics, Pharmacodynamics, and Disease.
Shukkoor MSA; Baharuldin MTH; Raja K
Methods Mol Biol; 2022; 2496():259-282. PubMed ID: 35713869
[TBL] [Abstract][Full Text] [Related]
19. Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database.
Chasioti D; Yao X; Zhang P; Lerner S; Quinney SK; Ning X; Li L; Shen L
IEEE J Biomed Health Inform; 2019 Sep; 23(5):2156-2163. PubMed ID: 30296244
[TBL] [Abstract][Full Text] [Related]
20. Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review.
Cocco M; Carnovale C; Clementi E; Barbieri MA; Battini V; Sessa M
Expert Rev Clin Pharmacol; 2024; 17(5-6):441-453. PubMed ID: 38619027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
